AWARDDEFINITIVE CONTRACTSmall business
Definitive contract HHSN272201500003CSTARKS ASSOCIATES, INC.
Overview
Award facts
- Net obligations
- $8.03M
- $8,025,498of $8.03M potential value
- Outlays (paid to date)
- $718.1K
- $718.1K paid of $8.03M obligated$718,096
- Period of performance
- Feb 16, 2015 to Feb 15, 2020
- Ended
- Modifications
- 14
- Latest action Sep 4, 2026
- Contract type
- Definitive contract
- PIID HHSN272201500003C
Contract value is the most the government could spend; obligations are what it has legally committed; outlays are what it has actually paid.
Description of requirement
IGF::OT::IGF - SYNTHESIS OF THERAPEUTIC AGENTS FOR TREATMENT OF INFECTIOUS DISEASES
Dates and value
- Award date
- Signed on Feb 12, 2015
- Potential end of performance
- Feb 15, 2022
- Current value
- $8,025,498Base and exercised options
- Potential value (if all options are exercised)
- $8,025,498
Obligations by fiscal year of action
- FY2026: -$103,674 (de-obligation)
- FY2025: -$49,413 (de-obligation)
- FY2024: -$50,833 (de-obligation)
- FY2023: $100,023
- FY2021: $1,256,425
- FY2020: $1,223,206
- FY2019: $1,190,876
- FY2018: $1,159,409
Show all 11 yearsEarlier years (FY2015–FY2017)
- FY2017: $1,128,779
- FY2016: $1,098,964
- FY2015: $1,071,736
Total across 11 fiscal years: $8,025,498
Net de-obligation in that fiscal year (obligations withdrawn).
Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded Sep 4, 2026. View on USAspending · Recipient on SAM.gov
Recipient
LocationBUFFALO, NY
UEIDAY5FJMYL4L8
CAGE code6R012
Business sizeSmall businessSize at award, per the contracting officer
Organization typeCorporate not tax exempt
Parent companySTARKS ASSOCIATES INC.
Business types and certifications
For-profit organizationSubchapter S corporationCorporation (not tax-exempt)
As represented in SAM.gov at the time of the action.
Subcontracting network
The prime, the subcontractors on this award, and their own subcontractors.
Agency and place
Awarding and funding
- Awarded by
- Department of Health and Human Services
- National Institutes Of Health
- NATIONAL INSTITUTES OF HEALTH NIAID
- Funded by
- Department of Health and Human Services
- National Institutes Of Health
- NATIONAL INSTITUTES OF HEALTH NIAID
- Funded from
- National institute of allergy and infectious diseases (0885)Program activities075-0885Federal accounts (agency financial reports)
Place of performance
- Place of performance
- Buffalo, Erie County, New York 14213-1503
- Congressional district (place of performance)
- NY-26As reported at the time of the action
Classification and competition
Classification
- Product or service (PSC)
- AN81R&D- MEDICAL: AIDS RESEARCH (BASIC RESEARCH) (research and development)
Competition
- Extent competed
- Full and open competition after exclusion of sourcesD
- Solicitation procedures
- Negotiated proposal/quoteNP
- Set-aside
- Small business set aside - totalSBA
- Contract pricing
- Cost plus fixed feeU
- Offers received
- 2
Solicitation and notices
- Solicitation ID
- RFPNIAIDNIHAI2013177(as reported)
Contract details
- Subcontracting plan
- Plan not requiredB
- Major program
- Synthesis of therapeutic agents for treatment of infectious diseases
- Cost Accounting Standards clause
- Not applicable exempt from CASX
- Certified cost or pricing data
- No
- Commercial procedures
- Commercial products/services procedures not usedD
- Government-furnished property
- Transaction does not use GFE/GFPN
- Bundled requirement
- Not a bundled requirementD
- Consolidated requirement
- No
- Undefinitized action (terms not final)
- No
- Multi-year contract
- No
- Performance-based service acquisition
- No - service where PBA is not used.N
Linked notices
Notice | Notice ID | Type | Link | Posted |
|---|---|---|---|---|
Transaction history
Modification history
- Base award
- Feb 12, 2015Base obligation at award: $1,071,736
- Latest action
- Sep 4, 2026 — Funding onlyModification P00014; obligation change -$103,674; funding only: changes obligations, not scope
- Latest substantive action
- Feb 10, 2021 — Option exercisedModification P00008; obligation change +$1,256,425
- Latest funding action
- Sep 4, 2026 — Funding onlyModification P00014; obligation change -$103,674; funding only: changes obligations, not scope
- Actions by type
- Base award1
- Option exercised6
- Funding only4
- Other administrative action4
Similar awards
PIID | Match | Awardee |
|---|---|---|
All contract data
All contract data
Every other field reported for this award, as of its latest reported action
Competition
- Evaluation preference
- No preference used
- Local area set-aside
- No
- Synopsized publicly (SAM.gov / FedBizOpps)
- Yes
- Simplified procedures for commercial items
- No
- A-76 (FAIR Act) action
- No
Pricing and financing
- Paid by purchase card
- No
- Latest action: change in base and exercised options
- -$103,674
- Latest action: change in base and all options
- -$103,674
Socio-economic and policy
- Inherently governmental functions
- Other functionsOT
- Recovered materials and sustainability
- No clauses included and no sustainability includedC
- EPA-designated product
- Not requiredE
- Clinger-Cohen Act planning (IT)
- No
Place and origin
- Domestic or foreign entity
- U.S. owned businessA
- Country of product or service origin
- United statesUSA
- Place of manufacture
- Not a manufactured end productC
Structure
- Award or IDV
- Award
- Award type
- Definitive contractD
- Awarding agency code
- 7500
- Awarding sub-tier code
- 7529
- Contracting office code
- 75N930
- Transactions recorded under this award key
- 15
Funding
- Funding agency code
- 7500
- Funding sub-tier code
- 7529
- Funding office code
- 75N930
- Treasury accounts
- 075-2017/2017-0885-000
- 075-2018/2018-0885-000
- 075-2019/2019-0885-000
- 075-2020/2020-0885-000
- 075-2021/2021-0885-000
- 075-2023/2023-0885-000
- Object classes
- 25.5: Research and development contracts
- Disaster or emergency funding (DEFC)
- Q: Not Designated Nonemergency/Emergency/Disaster/Wildfire Suppression